Unrealistic Expectations in the Diagnosis and Treatment of Ovarian Cancer

Jeffrey T. Kirchner; M. A. Friedman; B. A. Chabner; E. L. Trimble; J. Adams; S. G. Arbuck; Daniel J. Morris; Charles S. Eytel; Albert Kerns; Gene Wilder; C. D. Granai

doi:10.1056/NEJM199303043280915

Unrealistic Expectations in the Diagnosis and Treatment of Ovarian Cancer

Jeffrey T. Kirchner, M. A. Friedman, B. A. Chabner, E. L. Trimble, J. Adams, S. G. Arbuck, Daniel J. Morris, Charles S. Eytel, Albert Kerns, Gene Wilder, C. D. Granai

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Abstract

To the Editor: Dr. Granai's recent Sounding Board article, “Ovarian Cancer – Unrealistic Expectations” (July 16 issue),¹ succinctly highlights the problem of performing excessive screening tests for diseases for which we have no efficacious treatments. The author uses ovarian cancer as an example. A similar argument can be made for prostatic carcinoma, the most common cancer among American men². Despite the availability of transrectal ultrasonography, testing for prostate-specific antigen (PSA), and newer agents such as flutamide and leuprolide, the age-adjusted mortality for prostatic cancer has not changed since 1949²,³. Moreover, neither PSA testing nor transrectal ultrasonography is…

Original language	English (US)
Pages (from-to)	663-665
Number of pages	3
Journal	New England Journal of Medicine
Volume	328
Issue number	9
DOIs	https://doi.org/10.1056/NEJM199303043280915
State	Published - Mar 4 1993
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJM199303043280915

Cite this

@article{a2a280a3149742a0961dd4d282fb32b6,

title = "Unrealistic Expectations in the Diagnosis and Treatment of Ovarian Cancer",

abstract = "To the Editor: Dr. Granai's recent Sounding Board article, “Ovarian Cancer – Unrealistic Expectations” (July 16 issue),1 succinctly highlights the problem of performing excessive screening tests for diseases for which we have no efficacious treatments. The author uses ovarian cancer as an example. A similar argument can be made for prostatic carcinoma, the most common cancer among American men2. Despite the availability of transrectal ultrasonography, testing for prostate-specific antigen (PSA), and newer agents such as flutamide and leuprolide, the age-adjusted mortality for prostatic cancer has not changed since 19492,3. Moreover, neither PSA testing nor transrectal ultrasonography is…",

author = "Kirchner, {Jeffrey T.} and Friedman, {M. A.} and Chabner, {B. A.} and Trimble, {E. L.} and J. Adams and Arbuck, {S. G.} and Morris, {Daniel J.} and Eytel, {Charles S.} and Albert Kerns and Gene Wilder and Granai, {C. D.}",

year = "1993",

month = mar,

day = "4",

doi = "10.1056/NEJM199303043280915",

language = "English (US)",

volume = "328",

pages = "663--665",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "9",

}

TY - JOUR

T1 - Unrealistic Expectations in the Diagnosis and Treatment of Ovarian Cancer

AU - Kirchner, Jeffrey T.

AU - Friedman, M. A.

AU - Chabner, B. A.

AU - Trimble, E. L.

AU - Adams, J.

AU - Arbuck, S. G.

AU - Morris, Daniel J.

AU - Eytel, Charles S.

AU - Kerns, Albert

AU - Wilder, Gene

AU - Granai, C. D.

PY - 1993/3/4

Y1 - 1993/3/4

N2 - To the Editor: Dr. Granai's recent Sounding Board article, “Ovarian Cancer – Unrealistic Expectations” (July 16 issue),1 succinctly highlights the problem of performing excessive screening tests for diseases for which we have no efficacious treatments. The author uses ovarian cancer as an example. A similar argument can be made for prostatic carcinoma, the most common cancer among American men2. Despite the availability of transrectal ultrasonography, testing for prostate-specific antigen (PSA), and newer agents such as flutamide and leuprolide, the age-adjusted mortality for prostatic cancer has not changed since 19492,3. Moreover, neither PSA testing nor transrectal ultrasonography is…

AB - To the Editor: Dr. Granai's recent Sounding Board article, “Ovarian Cancer – Unrealistic Expectations” (July 16 issue),1 succinctly highlights the problem of performing excessive screening tests for diseases for which we have no efficacious treatments. The author uses ovarian cancer as an example. A similar argument can be made for prostatic carcinoma, the most common cancer among American men2. Despite the availability of transrectal ultrasonography, testing for prostate-specific antigen (PSA), and newer agents such as flutamide and leuprolide, the age-adjusted mortality for prostatic cancer has not changed since 19492,3. Moreover, neither PSA testing nor transrectal ultrasonography is…

UR - http://www.scopus.com/inward/record.url?scp=0027908408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027908408&partnerID=8YFLogxK

U2 - 10.1056/NEJM199303043280915

DO - 10.1056/NEJM199303043280915

M3 - Letter

C2 - 8094229

AN - SCOPUS:0027908408

SN - 0028-4793

VL - 328

SP - 663

EP - 665

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 9

ER -

Unrealistic Expectations in the Diagnosis and Treatment of Ovarian Cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this